期刊文献+

超敏C反应蛋白和LDL-C联合检测在诊断2型糖尿病并发大血管病变中的意义 被引量:2

Combinative monitoring of Hs-CRP and LDL-C on type 2 diabetes with vascular complications
下载PDF
导出
摘要 目的通过观察血清超敏C反应蛋白(HS-CRP)及低密度脂蛋白胆固醇(LDL-C)水平在2型糖尿病并发大血管病变中的变化,探讨其对糖尿病并发大血管病变监测的应用价值。方法收集60例2型糖尿病患者及50例正常体检者血清,全自动生化仪检测Hs-CRP、甘油三酯(TG)、LDL-C、总胆固醇(TC)、HDL-C、载脂蛋白(apoA1)、apoB。结果糖尿病患者无论有无大血管并发症其Hs-CRP、TG、LDL-C水平均明显高于对照组(P<0.05),大血管并发症组Hs-CRP、LDL-C水平明显高于无并发症组(P<0.05)。大血管并发症组血清Hs-CRP水平与LDL-C水平呈明显正相关(r=0.67,P<0.05),而在无大血管并发症组,Hs-CRP表达水平与LDL-C及其他血脂指标均无明显相关性。结论Hs-CRP及LDL-C联合检测可作为糖尿病及糖尿病并发大血管损伤的监测指标。 Objective To investigate the relationship between Hs-CRP,LDL-C and type 2 diabetes with vascular complications. Methods The levels of Hs-CRP,TG,LDL-C,TC,HDL-C,apoA1 ,apoB were detected on 60 diabetes patients with/without vascular complications and 50 healthy subjects. Results Compared with those of control group,the concentrations of CRP,TG and LDL- C were higher significantly in diabetes group; the levels of Hs-CRP and LDL-C in diabetes with vascular complications were higher than those of without complications; the pattern of Hs-CRP and LDL-C expression in diabetes with vascular complications showed a statistically significant correlation. Conclusion Combinative monitoring of Hs-CRP and LDL can be used to predict diabetes with vascular complications.
出处 《重庆医学》 CAS CSCD 2006年第17期1543-1544,共2页 Chongqing medicine
关键词 2型糖尿病 C反应蛋白 大血管病变 type Ⅱ diabetes mellitus C-reactive protein vascular complications
  • 相关文献

参考文献5

  • 1van-Hecke MV,Dekker JM,Nijpels G,et al.Inflammation and endothelial dysfunction are associated with retinopathy:the Hoorn Study[J].Diabetologia,2005,48(7):1300 被引量:1
  • 2Woodman RJ,Watts GF,Puddey IB,et al.Leukocyte count and vascular function in Type 2 diabetic subjects with treated hypertension[J].Atherosclerosis,2002,163(1):175 被引量:1
  • 3Pickup JC,Crook MA.Is type Ⅱ diabetes mellitus a disease of the innate immune system[J].Diabetologia,1998,41(10):1241 被引量:1
  • 4Ajjan R,Grant PJ,Futers TS,et al Complement C3 and C-reactive protein levels in patients with stable coronary artery disease[J].Thromb Haemost,2005,94(5):1048 被引量:1
  • 5The Diabetes Prevention Program Research Group.Lipid,lipoproteins,C-reactive protein,and hemostatic factors at baseline in the diabetes prevention program[J].Diabetes Care,2005,28(10):2472 被引量:1

同被引文献19

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部